|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-6-22
|
|
pubmed:abstractText |
The aim of this study was to compare the efficacy of lamivudine therapy between chronic hepatitis B (CHB) patients, whose ALT levels less than 2 times the upper limit of normal (ULN) and patients whose ALT levels are more than 2 times ULN.
|
|
pubmed:language |
kor
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1738-222X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
146-56
|
|
pubmed:dateRevised |
2010-7-29
|
|
pubmed:meshHeading |
pubmed-meshheading:17585188-Adolescent,
pubmed-meshheading:17585188-Adult,
pubmed-meshheading:17585188-Aged,
pubmed-meshheading:17585188-Alanine Transaminase,
pubmed-meshheading:17585188-Antiviral Agents,
pubmed-meshheading:17585188-Drug Resistance, Viral,
pubmed-meshheading:17585188-Female,
pubmed-meshheading:17585188-Hepatitis B, Chronic,
pubmed-meshheading:17585188-Hepatitis B e Antigens,
pubmed-meshheading:17585188-Humans,
pubmed-meshheading:17585188-Lamivudine,
pubmed-meshheading:17585188-Male,
pubmed-meshheading:17585188-Middle Aged,
pubmed-meshheading:17585188-Prognosis,
pubmed-meshheading:17585188-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Clinical outcomes of lamivudine therapy in HBeAg positive chronic hepatitis B with minimally elevated ALT].
|
|
pubmed:affiliation |
Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
